7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiovascular Pharmacology and Therapeutics
The role of cardiovascular pharmacology and therapeutics extends far beyond traditional drug regimens, encompassing groundbreaking treatments that address the intricate mechanisms of heart diseases. Recent developments include RNA-based therapies and regenerative drugs designed to repair cardiac tissue at a molecular level. Researchers are also investigating the role of anti-inflammatory agents in reducing atherosclerosis progression. Clinical trials for novel anticoagulants and lipid-lowering medications continue to refine strategies for preventing thrombotic events and improving long-term patient health. This dynamic field integrates pharmacological advances with patient-specific approaches to enhance both the efficacy and safety of cardiovascular care.
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States
Mekhman N Mamedov
National Research Center for Therapy and Preventive Medicine, Russian Federation
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation